The impact of ADHD on the cognitive and academic functioning of children with NF1

Developmental Neuropsychology

Volumn 37, Issue 7, 2012, Pages 590-600

  Pride, Natalie A ^a,b   Payne, Jonathan M ^a,b   North, Kathryn N ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COGNITIVE DEFECT; FEMALE; HUMAN; LEARNING DISORDER; MALE; NEUROFIBROMATOSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; LEARNING DISORDERS; LINEAR MODELS; MALE; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84867826988     PISSN: 87565641     EISSN: None     Source Type: Journal    
DOI: 10.1080/87565641.2012.695831     Document Type: Article

References (48)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th, Washington, DC: Author.
2. Anderson, P. 2002. Assessment and development of executive function (EF) during childhood. Child Neuropsychology, 8: 71-82.
3. Anderson, V., Lajoie, G., and, Bell, R. 1995. Neuropsychological assessment of the school-aged child. In Melbourne, University of Melbourne: Australia: Department of Psychology.
4. Banerjee, T. D., Middleton, F., and, Faraone, S. V. 2007. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pediatrica, 96: 1269-1274.
5. Barkley, R. A. 1997. Behavioral inhibition, sustained attention, and executive function: Constructing a unifying theory of ADHD. Psychological Bulletin, 121 (1): 65-94.
6. Barkley, R. A., and, Fischer, M. 2011. Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: Self-reported executive function (EF) deficits versus EF tests. Developmental Neuropsychology, 36 (2): 137-161.
7. Barkley, R. A., and, Murphy, K. R. 2010. Impairment in occupational functioning and adult ADHD: The predictive utility of executive function (EF) ratings versus EF tests. Archives of Clinical Neuropsychology, 25: 157-173.
8. Barton, B., and, North, K. 2004. Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46: 553-563.
9. Baumaerterl, A., Wolraich, M. L., and, Dietrich, M. 1995. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. Journal of American Academy of Child Adolescent Psychiatry, 34: 629-638.
10. Benton, A., Varney, N., and, Hamsher, K. 1976. Judgment of line orientation, Iowa City: Department of Neurology, University of Iowa.
11. Boll, T. 1997. Children's category test, San Antonio, TX: The Psychological Corporation.
12. Brown, J. A., Emnett, R. J., White, C. R., Yuede, C. M., Conyers, S. B., O'Malley, K. L., and, Gutmann, D. H. 2010. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Human Molecular Genetics, 19: 4515-4528.
13. Brown, J. A., Xu, J., Diggs-Andrews, K. A., Wozniak, D. F., Mach, R. H., and, Gutmann, D. H. 2011. PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Experimental Neurology, 232: 333-338.
14. Castellanos, F. X., and, Tannock, R. 2002. Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nature Reviews Neuroscience, 3: 617-628.
15. Conners, C. K. 1997. Conners' Rating Scales-Revised, New York, NY: Multi-Health Systems.
16. Cooley, E. L., and, Morris, R. D. 1990. Attention in children: A neuropsychologically based model for assessment. Developmental Neuropsychology, 6 (3): 239-274.
17. Delis, D., Kramer, J., Kaplan, E., and, Ober, B. 1994. The Californian Verbal Learning Test for Children, New York, NY: Psychological Corporation.
18. DeShazo, B. T., Lyman, R. D., and, Klinger, L. G. 2002. Academic underachievement in attention deficit/hyperactivity disorder: The negative impact of symptom severity on school performance. Journal of School Psychology, 40 (3): 259-283.
19. Froehlich, T. E., Lanphear, B. P., Epstein, J. N., Barbaresi, W. J., Katusic, S. K., and, Kahn, R. S. 2007. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatric Adolescent Medicine, 161 (9): 857-864.
20. Gaub, M., and, Carlson, C. L. 1997. Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. Journal of Abnormal Child Psychology, 25: 103-111.
21. Gioia, G., Isquith, P., Guy, S., and, Kenworthy, L. 2000. Behavior Rating Inventory of Executive FunctionProfessional Manual, Odessa, FL: Psychological Assessment Resources.
22. Gioia, G. A., Isquith, P. K., Kenworthy, L., and, Barton, R. M. 2002. Profiles of everyday executive function in acquired and developmental disorders. Child Neuropsychology, 8: 121-137.
23. Graetz, B. W., Sawyer, M. G., Hazell, P. L., Arney, F., and, Baghurst, P. 2001. Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 40: 1410-1417.
24. Holm, S. 1979. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6: 65-70.
25. Hyman, S. L., Shores, E. A., and, North, K. N. 2005. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65: 1037-1044.
26. Hyman, S. L., Shores, E. A., and, North, K. N. 2006. Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology, 48: 973-977.
27. Kayl, A. E., Moore, B. D., Slopis, J. M., Jackson, E. F., and, Leeds, N. E. 2000. Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. Journal of Child Neurology, 15: 90-96.
28. Korkman, M., Kirk, U., and, Kemp, S. 1998. NEPSY: A developmental neuropsychological assessment-manual, New York, NY: Psychological Corporation.
29. Koth, C. W., Cutting, L. E., and, Denckla, M. B. 2000. The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychology, 6: 185-194.
30. Krikorian, R., Bartok, J., and, Gay, N. 1994. Tower of London procedure: A standard method and developmental data. Journal of Clinical & Experimental Neuropsychology, 16: 840-850.
31. Lahey, B. B., Pelham, W. E., Loney, J., Lee, S. S., and, Willcutt, E. 2005. Instability of the DSM-IV subtypes of ADHD from preschool through elementary school. Archives of General Psychiatry, 62: 896-902.
32. Levine, T. M., Materek, A., Abel, J., O'Donnell, M., and, Cutting, L. E. 2006. Cognitive profile of neurofibromatosis type 1. Seminars in Pediatric Neurology, 13: 8-20.
33. Lionel, A. C., Crosbie, J., Barbosa, N., Goodale, T., Thiruvahindrapuram, B., Rickaby, J., and, Scherer, S. W. 2010. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Science Translational Medicine, 3 (95) doi: 10.1126/scitranslmed.30002464
34. Manly, T., Robertson, I. H., Anderson, V., and, Nimmo-Smith, I. 1999. The test of everyday attention for children, London, England: Battley Brothers.
35. Mautner, V. F., Kluwe, L., Thakker, S. D., and, Leark, R. A. 2002. Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44: 164-170.
36. National Institutes of Health (NIH) Consensus Development Conference. 1988. Neurofibromatosis Conference Statement. Archives of Neurology, 45: 575-578.
37. Payne, J. M., Hyman, S. L., Shores, E. A., and, North, K. N. 2011. Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior. Child Neuropsychology, 17 (4): 313-329.
38. Pennington, B. F., and, Ozonoff, S. 1996. Executive function and developmental psychopathology. Journal of Child Psychology and Psychiatry, 37 (1): 51-87.
39. Preston, A. S., Heaton, S. C., McCann, S. J., Watson, W. D., and, Selke, G. 2009. The role of multidimensional attentional abilities in academic skills of children with ADHD. Journal of Learning Disabilities, 42 (3): 240-249.
40. Roy, A., Roulin, J. L., Charbonnier, V., Allain, P., Fasotti, L., Barbarot, S., and, LeGall, D. 2010. Executive dysfunction in children with neurofibromatosis type 1: A study of action planning. Journal of International Neuropsychological Society, 16: 1056-1063.
41. Schachar, R., Mota, V. L., Logan, G. D., Tannock, R., and, Klim, P. 2000. Confirmation of an inhibitory control deficit in attention-deficit/ hyperactivity disorder. Journal of Abnormal Child Psychology, 28: 227-235.
42. Shilyansky, C., Karlsgodt, K. H., Cummings, D. M., Sidiropoulou, K., Hardt, M., James, A. S., and, Silva, A. J. 2010. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proceedings of the National Academy of Sciences, 107: 13141-13146.
43. Wechsler, D. 1991. Wechsler Intelligence Scale for Children, 3, New York, NY: The Psychological Corporation.
44. Wechsler, D. 1992. Wechsler Individual Achievement Test, New York, NY: Psychological Corporation.
45. Wechsler, D. 2002. Wechsler Individual Achievement Test Second Edition: Australian Standardized Edition, NSW, Australia: Harcourt Assessment.
46. Wechsler, D. 2003. Wechsler Intelligence Scale for Children, 4, San Antonio, TX: The Psychological Corporation.
47. Wilcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., and, Pennington, B. F. 2005. Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biological Psychiatry, 57: 1336-1346.
48. Williams, N. M., Zaharieva, I., Martin, A., Langley, K., Mantripragada, K., Fossdal, R., and, Thapar, A. 2010. Rare chromosomal deletions and duplication in attention-deficit hyperactivity disorder: A genome-wide analysis. Lancet, 376: 1401-1408.